Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Rizzotto

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2025
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferationArturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, et al.
Blood|January 17, 2012
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parametersGian Matteo Rigolin, Francesca Cibien, Sara Martinelli, et al.
The Journal of Experimental Medicine|July 21, 2021
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanomaRoberto Vendramin, Vicky Katopodi, Sonia Cinque, et al.
Experimental Hematology|November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemiaRossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 13, 2025
Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancerJoseph Mills, Anna Tessari, Vollter Anastas, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2025
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferationArturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, et al.
Blood|January 17, 2012
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parametersGian Matteo Rigolin, Francesca Cibien, Sara Martinelli, et al.
The Journal of Experimental Medicine|July 21, 2021
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanomaRoberto Vendramin, Vicky Katopodi, Sonia Cinque, et al.
Experimental Hematology|November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemiaRossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 13, 2025
Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancerJoseph Mills, Anna Tessari, Vollter Anastas, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Pageof 4